Compare Indo Oil Perkasa Tbk. (OILS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indo Oil Perkasa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indo Oil Perkasa Tbk. trades at Rp312 (market cap 136.22B, 104.97M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indo Oil Perkasa Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| OILS | SCPI | |
|---|---|---|
Market Cap | 136.22B | 104.4B |
Volume | 104.97M | — |
Lot | 1.05M | — |
Turnover | 34.91B | — |
Average Price | 332.57 | — |
Value | 34.91B | — |
Indicative Equilibrium Price | 312 | — |
Indicative Equilibrium Volume | 3.49K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indo Oil Perkasa Tbk.
PT Indo Oil Perkasa Tbk (the Company) was established in Mojokerto based on the Notarial Deed No. 02 of Dr. CH. Anggia Ika HDKW., S.H. M.Hum, dated January 05, 2016. The Company commenced its commercial operations in 2017.
Read more on OILS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
